Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Bullboard Posts
Post by KnowledgeSeeker1on Nov 28, 2012 6:05pm
201 Views
Post# 20657314

Unbelievable

Unbelievable

Unbelievable that this is coming close to testing it's 52 week low.  Of course why should this stock be any different than most other Venture stocks sp over the last 18 months.

I guess this is where everyone's intestinal fortitude gets checked.  I've seen the sp rally from this level a number of times but it tends to be a slow process and then move suddenly on news.  Let's get the heck out of 2012 and hope for better in 2013.

?Unlike many Venture companies this one doesn't dilute excessively and hopefully if sales of their products coming to market are good they won't need to.  The advertising talks about growing revenue from their flagship product and that they expect future orders.

I still think this is a great level to add more if you have any spare change kicking around.

GLTA.

Bullboard Posts